🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT07552844
Starting soon Not applicable

Effects of 8-Week CrossFit-Based Concurrent Training on Fitness, Body Composition, and Psychological Outcomes in Schoolchildren

NCT07552844 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-06
Last updated
2026-04-30

Condition(s) studied

ChildrenCrossfitPsychology, ChildPhysical FitnessBody Composition

Investigational drug(s) / intervention(s)

CrossFit training

CrossFit training: The experimental arm will receive an 8-week concurrent training intervention based on a CrossFit program adapted for children, with a frequency of two 50-minute sessions per week. Each session will be structured into a warm-up (mobility exercises and games), strength training (technical and functional exercises), metabolic conditioning (METCON), and a cool-down phase. The program will be supervised by qualified professionals to ensure safety and proper execution of the exercises.

Study summary

This study examines the effects of an 8-week CrossFit-based concurrent training program in boys and girls aged 7 to 11 years, comparing an experimental group (n=15) with a control group (n=15). The aim is to assess changes in strength, cardiorespiratory fitness, body composition, and psychological variables such as anxiety, stress, and self-esteem, using field-based physical tests (CMJ, Course Navette, handgrip strength, etc.) and validated questionnaires. The study follows a randomized controlled trial design with pre- and post-intervention assessments. The experimental group will complete two weekly CrossFit sessions adapted for children, while the control group will maintain their usual routine without structured physical training. The hypothesis states that the intervention will significantly improve both physical performance and psychological well-being in the experimental group compared to the control group.

Eligibility

Sex
ALL
Min age
7 Years
Max age
11 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age: 7-11 years. * Students enrolled at CEIP Pablo García Baena (Córdoba). For the experimental group: * Availability to attend the Triple XXX Box (Polígono Pedroches, C. los Alfareros, Parcel 119, 14014 Córdoba), where both assessments and training sessions will be conducted. * Availability to attend training sessions twice per week for the 8-week intervention period. * No participation in extracurricular physical activity prior to the start of the CrossFit program. For the control group: No participation in extracurricular physical activity. Informed consent signed by parents or legal guardians. No medical, psychological, or behavioral contraindications that would prevent participation in physical activity. Exclusion Criteria: * Children with musculoskeletal injuries, diseases, or medical, psychological, or behavioral conditions that limit physical activity or interfere with the assessment of outcomes. * Inability or anticipated difficulty in regularly attending training sessions. * Refusal of parents or legal guardians to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IMIBIC Córdoba Córdoba

More Maimónides Biomedical Research Institute of Córdoba trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07552844 on ClinicalTrials.gov ↗ ← All trials in Spain